SC: Confirmation of an Auction Sale Does Not Bar Judicial Scrutiny of Reserve Price Valuation  ||  Supreme Court Sets Aside Conviction of Four Men in a 1998 Gang Rape Case  ||  Supreme Court: Privy Purse Privileges of Princely Rulers are Not Enforceable Legal Rights  ||  Delhi HC: Repeated Court Summons May Distress and Re-Traumatize Child Sexual Assault Victims  ||  Jammu and Kashmir High Court: Labeling Someone as a Terrorist Associate Amounts to Defamation  ||  Delhi HC: Setting Aside or Altering a Judge’s Order by a Higher Court Doesn’t Affect Their Integrity  ||  Delhi High Court: Accused Cannot be Faulted For Smart Replies; Interrogator Must be Sharper  ||  Supreme Court: Belated Jurisdictional Challenge Impermissible After Participation in Arbitration  ||  Supreme Court: Failure to Prove Specific Overt Acts of Each Unlawful Assembly Member Not Fatal  ||  Supreme Court: Parental Salary Alone Cannot Determine OBC Creamy Layer Status    

Central Government permitted M/s. Cipla Limited to import morphine, codeine, the baine and their salts after following the procedure specified in NDPS Rules- (Ministry of Finance ) (27 Aug 2020)

MANU/REVU/0064/2020

Law of Medicine

1. In exercise of the powers conferred by the proviso to rule 54 of the Narcotic Drugs and Psychotropic Substances Rules, 1985, the Central Government hereby notifies that M/s. Cipla Limited, Cipla House, Peninsula Business Park, Ganpatrao Kadma Marg, Lower Parel, Mumbai-400013, is permitted to import morphine, codeine, thebaine and their salts for use in manufacture of products to be exported, after following the procedure specified in Rule 55 of the said rules and subject to such conditions as may be specified in the import certificate issued in Form No. 4A annexed to the aforesaid rules.

2. This notification shall remain in force from the date of its publication in the Official Gazette till the 31st day of December, 2022.

Tags : CIPLA LIMITED   PERMISSION   IMPORT  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved